Novolog (Pharm-Up 1966) Ltd (NVLG.TA)
ILA 181.1
(0.39%)
ILA 181.1
(0.39%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.64 Billion | 1.5 Billion | 1.25 Billion | 1.13 Billion | 1 Billion | 911.23 Million |
| Cost of Revenue | 1.47 Billion | 1.33 Billion | 1.1 Billion | 1 Billion | 905.5 Million | 826.91 Million |
| Gross Profit | 169.16 Million | 176.14 Million | 148.95 Million | 129.28 Million | 98.63 Million | 84.32 Million |
| Operating Expenses | 171.11 Million | 97.63 Million | 81.09 Million | 74.5 Million | 64.98 Million | 50.11 Million |
| Selling, General and Administrative Expenses | 123.29 Million | 16.05 Million | 12.37 Million | 11.18 Million | 10.69 Million | 8.44 Million |
| Research and Development Expenses | 536 Thousand | 536 Thousand | - | - | - | - |
| Other Expenses | 47.28 Million | -68 Thousand | 1.54 Million | 2.74 Million | -2.4 Million | -2.79 Million |
| Cost and Expenses | 1.64 Billion | 1.42 Billion | 1.18 Billion | 1.07 Billion | 970.49 Million | 877.03 Million |
| Operating Income | 2.65 Million | 78.77 Million | 69.93 Million | 61.09 Million | 33.06 Million | 31.39 Million |
| Interest Expense | 12.86 Million | 12.53 Million | 8.46 Million | 6.78 Million | 7.3 Million | 1.07 Million |
| Income Tax Expense | 10.47 Million | 17.12 Million | 15.3 Million | 11.96 Million | 8.22 Million | 8.64 Million |
| Earnings before Tax | 1.73 Million | 73.13 Million | 61.76 Million | 52.52 Million | 18.36 Million | 30.5 Million |
| Net Income | -42 Million | 47.51 Million | 42.31 Million | 40.06 Million | 10.13 Million | 21.86 Million |
| Earnings Per Share Basic | -0.08 | 0.09 | 0.08 | 0.09 | 0.03 | 0.06 |
| Earnings Per Share Diluted | -0.08 | 0.09 | 0.08 | 0.08 | 0.03 | 0.06 |
| Weighted Average Shares Outstanding | 509.81 Million | 507.27 Million | 505.45 Million | 463.5 Million | 386.87 Million | 350 Million |
| Weighted Average Shares Outstanding (Diluted) | 510.92 Million | 515.79 Million | 515.07 Million | 472.2 Million | 386.87 Million | 350 Million |
| Gross Margin | 0.10 | 0.12 | 0.12 | 0.11 | 0.10 | 0.09 |
| EBIT Margin | 0.08 | 0.09 | 0.09 | 0.09 | 0.07 | 0.06 |
| Profit Margin | -0.03 | 0.03 | 0.03 | 0.04 | 0.01 | 0.02 |
| EBITDA | 130.13 Million | 138.52 Million | 115.92 Million | 104.05 Million | 70.26 Million | 52.62 Million |
| Earnings Before Tax Margin | 0.00 | 0.05 | 0.06 | 0.05 | 0.03 | 0.03 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 427.96 Million | 438.04 Million | 1.64 Billion | 396.45 Million | 420.78 Million | 413.05 Million |
| Cost of Revenue | 384.44 Million | 389.76 Million | 1.47 Billion | 358.95 Million | 381.81 Million | 366.86 Million |
| Gross Profit | 43.52 Million | 48.28 Million | 169.16 Million | 37.49 Million | 38.96 Million | 46.19 Million |
| Operating Expenses | 26.44 Million | 27.57 Million | 118.74 Million | 32.39 Million | 31.07 Million | 28.7 Million |
| Selling, General and Administrative Expenses | 26.44 Million | 27.57 Million | - | -59.59 Million | 31.07 Million | 28.7 Million |
| Research and Development Expenses | - | - | - | 536 Thousand | - | - |
| Other Expenses | 106 Thousand | -167 Thousand | 7.37 Million | 12.55 Million | -5.4 Million | -453 Thousand |
| Cost and Expenses | 410.88 Million | 417.34 Million | 1.59 Billion | 391.35 Million | 412.89 Million | 395.57 Million |
| Operating Income | 17.19 Million | 20.43 Million | 2.65 Million | -37.48 Million | -2.48 Million | 17.03 Million |
| Interest Expense | 3.46 Million | 6.9 Million | 12.86 Million | 3.23 Million | 3.1 Million | 3.29 Million |
| Income Tax Expense | 4.25 Million | 5.06 Million | 10.47 Million | 233 Thousand | 2.18 Million | 4.06 Million |
| Earnings before Tax | 17.63 Million | 18.34 Million | 1.73 Million | -39.66 Million | 4.12 Million | 18.18 Million |
| Net Income | 13.25 Million | 12 Million | -42 Million | -43.52 Million | 332 Thousand | 11.22 Million |
| Earnings Per Share Basic | 0.03 | 0.02 | - | -0.09 | 0.00 | 0.02 |
| Earnings Per Share Diluted | 0.03 | 0.02 | - | -0.09 | 0.00 | 0.02 |
| Weighted Average Shares Outstanding | 510.71 Million | 510.71 Million | 509.81 Million | 510.73 Million | 510.69 Million | 509.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 510.71 Million | 510.71 Million | 510.92 Million | 510.72 Million | 510.9 Million | 510.59 Million |
| Gross Margin | 0.10 | 0.11 | 0.10 | 0.09 | 0.09 | 0.11 |
| EBIT Margin | 0.09 | 0.10 | - | 0.06 | 0.08 | 0.09 |
| Profit Margin | 0.03 | 0.03 | -0.03 | -0.11 | 0.00 | 0.03 |
| EBITDA | 37.84 Million | 41.98 Million | - | 22.77 Million | 33.25 Million | 36.79 Million |
| Earnings Before Tax Margin | 0.04 | 0.05 | 0.00 | -0.09 | -0.01 | 0.04 |
6291
LOGC
FCBC
189300
TRITN
OIZ